AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
AAPL   381.37 (+2.33%)
MSFT   212.83 (+2.20%)
FB   243.58 (+1.13%)
GOOGL   1,503.60 (+0.92%)
AMZN   3,081.11 (+2.70%)
NVDA   408.64 (+3.49%)
CGC   16.33 (-1.03%)
BABA   257.68 (+8.95%)
MU   49.71 (+1.26%)
GE   6.86 (+1.48%)
TSLA   1,365.88 (-1.73%)
AMD   53.43 (+0.94%)
T   30.46 (+0.46%)
ACB   12.16 (-2.09%)
F   6.09 (-0.49%)
GILD   75.61 (-1.06%)
DIS   116.66 (+2.67%)
BAC   23.10 (+0.39%)
NFLX   502.78 (+1.95%)
BA   180.08 (+0.67%)
Log in

NASDAQ:SGRYSurgery Partners Stock Price, Forecast & News

$12.11
+0.64 (+5.58 %)
(As of 07/8/2020 04:00 PM ET)
Add
Compare
Today's Range
$11.36
Now: $12.11
$12.20
50-Day Range
$10.47
MA: $12.66
$15.36
52-Week Range
$4.00
Now: $12.11
$19.74
Volume479,646 shs
Average Volume795,397 shs
Market Capitalization$611.77 million
P/E RatioN/A
Dividend YieldN/A
Beta3.43
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care; and a suite of ancillary services, which consist of a diagnostic laboratory, multi-specialty physician practices, urgent care facilities, anesthesia services, and optical services. It also operates optical laboratory that manufactures eyewear. As of December 31, 2018, the company owned or operated a portfolio of 123 surgical facilities, including 108 ambulatory surgical centers and 15 surgical hospitals in 31 states. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Read More
Surgery Partners logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.57 out of 5 stars


Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SGRY
CUSIPN/A
Phone615-234-5900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.83 billion
Cash Flow$0.52 per share
Book Value$19.67 per share

Profitability

Net Income$-74,800,000.00

Miscellaneous

Employees9,600
Market Cap$611.77 million
Next Earnings Date8/5/2020 (Estimated)
OptionableOptionable

Receive SGRY News and Ratings via Email

Sign-up to receive the latest news and ratings for SGRY and its competitors with MarketBeat's FREE daily newsletter.

Surgery Partners (NASDAQ:SGRY) Frequently Asked Questions

How has Surgery Partners' stock been impacted by COVID-19 (Coronavirus)?

Surgery Partners' stock was trading at $8.86 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SGRY stock has increased by 36.7% and is now trading at $12.11. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Surgery Partners?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Surgery Partners.

When is Surgery Partners' next earnings date?

Surgery Partners is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Surgery Partners.

How were Surgery Partners' earnings last quarter?

Surgery Partners Inc (NASDAQ:SGRY) announced its quarterly earnings data on Monday, May, 11th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.62) by $0.28. The company earned $441 million during the quarter, compared to the consensus estimate of $377.50 million. Surgery Partners had a negative return on equity of 2.21% and a negative net margin of 4.38%. View Surgery Partners' earnings history.

What price target have analysts set for SGRY?

4 brokers have issued twelve-month price objectives for Surgery Partners' stock. Their forecasts range from $14.00 to $19.00. On average, they anticipate Surgery Partners' stock price to reach $15.50 in the next twelve months. This suggests a possible upside of 28.0% from the stock's current price. View analysts' price targets for Surgery Partners.

Has Surgery Partners been receiving favorable news coverage?

Press coverage about SGRY stock has been trending negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Surgery Partners earned a news sentiment score of -2.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about Surgery Partners.

Are investors shorting Surgery Partners?

Surgery Partners saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 3,040,000 shares, a drop of 10.6% from the June 15th total of 3,400,000 shares. Based on an average daily trading volume, of 1,050,000 shares, the short-interest ratio is presently 2.9 days. Currently, 12.9% of the company's stock are short sold. View Surgery Partners' Current Options Chain.

Who are some of Surgery Partners' key competitors?

What other stocks do shareholders of Surgery Partners own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Surgery Partners investors own include Verizon Communications (VZ), Allena Pharmaceuticals (ALNA), Bank of America (BAC), Netflix (NFLX), NVIDIA (NVDA), Ring Energy (REI), Ring Energy (REI), Advanced Micro Devices (AMD), Alteryx (AYX) and Carnival (CCL).

Who are Surgery Partners' key executives?

Surgery Partners' management team includes the following people:
  • Mr. Wayne Scott DeVeydt, CEO & Director (Age 49)
  • Mr. Thomas Francis Cowhey, Exec. VP, CFO & Principal Accounting Officer (Age 47)
  • Ms. Jennifer B. Baldock, Exec. VP & Chief Legal Officer (Age 48)
  • Dr. Angela Justice Ph.D., Exec. VP & Chief HR Officer (Age 46)
  • Mr. George M. Goodwin, Pres of American Group (Age 58)

What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

How do I buy shares of Surgery Partners?

Shares of SGRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $12.11.

How big of a company is Surgery Partners?

Surgery Partners has a market capitalization of $611.77 million and generates $1.83 billion in revenue each year. The company earns $-74,800,000.00 in net income (profit) each year or ($1.10) on an earnings per share basis. Surgery Partners employs 9,600 workers across the globe.

What is Surgery Partners' official website?

The official website for Surgery Partners is www.surgerypartners.com.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The company can be reached via phone at 615-234-5900 or via email at [email protected]

This page was last updated on 7/8/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.